» Articles » PMID: 32736574

Genome-wide DNA Methylation Profiling Identifies Epigenetic Signatures of Gastric Cardiac Intestinal Metaplasia

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2020 Aug 2
PMID 32736574
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Measuring the DNA methylome may offer the opportunity to identify novel disease biomarkers and insights into disease mechanisms. Although aberrant DNA methylation has been investigated in many human cancers and precancerous lesions, the DNA methylation landscape of gastric cardiac intestinal metaplasia (IM) remains unknown. Therefore, we aimed to investigate the genome-wide DNA methylation landscape and to search for potential epigenetic biomarkers of gastric cardiac IM.

Methods: Histopathologic profiling was performed on a total of 118 gastric cardiac biopsies from cancer-free individuals. Genome-wide DNA methylation analysis was performed on 11 gastric cardiac mucosal biopsies (IM = 7; normal = 4) using Illumina 850K microarrays. Transcriptional relevance of any candidate epigenetic biomarker was validated by qRT-PCR.

Results: The detection rate of gastric cardiac IM was 23% (27/118) in cancer-free individuals. Genome-wide DNA methylation profiling showed a global decrease in methylation in IM compared with normal tissues (median methylation = 0.64 and 0.70 for gastric cardiac IM and normal tissues, respectively). Differential methylation analysis between gastric cardiac IM and normal tissues identified 38,237 differentially methylated probes (DMPs) with a majority of sites showing hypermethylation in IM compared with normal tissues (56.3% vs. 43.7%). Subsequent analysis revealed a significant enrichment of hypermethylated DMPs in promoter and CpG islands (p < 0.001 for both, Pearson χ test). For DMPs located in promoter CpG islands showing extreme hypermethylation, the candidate gene with the largest number of DMPs (n = 7) was mapped to HOXA5. Accordingly, mRNA expression of HOXA5 was significantly reduced in IM compared to normal tissue.

Conclusions: Our results suggest the implication of alterations in DNA methylation in gastric cardiac IM and highlight that HOXA5 hypermethylation may be a promising epigenetic biomarker, emphasizing the role of aberrant HOXA5 expression in the pathogenesis of gastric cardiac IM.

Citing Articles

Cellular plasticity and fate determination in gastric carcinogenesis.

He Z, Hu X, He T, Zhao T iScience. 2024; 27(4):109465.

PMID: 38550991 PMC: 10973593. DOI: 10.1016/j.isci.2024.109465.


Genome-wide DNA methylation pattern in whole blood of patients with Hashimoto thyroiditis.

Zhou Z, Liu J, Chen Y, Ren B, Wan S, Chen Y Front Endocrinol (Lausanne). 2023; 14:1259903.

PMID: 38075038 PMC: 10704911. DOI: 10.3389/fendo.2023.1259903.


Aberrant DNA methylation and expression of in gastric cardia intestinal metaplasia.

Li C, Liu Z, Xu G, Wu S, Peng Y, Wu R Saudi J Gastroenterol. 2022; 28(6):456-465.

PMID: 36453428 PMC: 9843510. DOI: 10.4103/sjg.sjg_228_22.


Integrated Analysis of Multi-Omics Data to Establish a Hypoxia-Related Prognostic Model in Osteosarcoma.

Tong Y, Zhang X, Zhou Y Evol Bioinform Online. 2022; 18:11769343221128537.

PMID: 36325183 PMC: 9618759. DOI: 10.1177/11769343221128537.


Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Sugano K, Spechler S, El-Omar E, McColl K, Takubo K, Gotoda T Gut. 2022; 71(8):1488-1514.

PMID: 35725291 PMC: 9279854. DOI: 10.1136/gutjnl-2022-327281.


References
1.
Huang K, Ramnarayanan K, Zhu F, Srivastava S, Xu C, Tan A . Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. Cancer Cell. 2018; 33(1):137-150.e5. DOI: 10.1016/j.ccell.2017.11.018. View

2.
Berman D, Karhadkar S, Maitra A, Montes de Oca R, Gerstenblith M, Briggs K . Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003; 425(6960):846-51. DOI: 10.1038/nature01972. View

3.
Daugaard I, Dominguez D, Kjeldsen T, Kristensen L, Hager H, Wojdacz T . Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma. Sci Rep. 2016; 6:35807. PMC: 5080630. DOI: 10.1038/srep35807. View

4.
Linehan W, Ricketts C . The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019; 16(9):539-552. DOI: 10.1038/s41585-019-0211-5. View

5.
Strathdee G, Sim A, Soutar R, Holyoake T, Brown R . HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. Carcinogenesis. 2006; 28(2):299-309. DOI: 10.1093/carcin/bgl133. View